Literature DB >> 11868989

RNA-protein interactions that regulate pre-mRNA splicing.

Ravinder Singh1.   

Abstract

Splicing of nuclear precursor messenger RNAs is an important and ubiquitous type of gene regulation in metazoans. Splicing joins the coding sequences called exons by removing the intervening noncoding sequences, introns, from primary transcripts. Alternative splicing generates an enormous repertoire of functional diversity by producing multiple RNAs and proteins from a single gene. In fact, recent genome sequences from several organisms suggest that splicing regulation is likely to provide an important source of functional diversity in more complex organisms. Because splice sites are short sequences at the ends of introns, the functional splice sites have to be distinguished from an excessively large number of sequences in the primary transcripts that resemble a splice site. Furthermore, alternative splice sites have to be correctly chosen at appropriate times. Thus, selection of proper splice sites remains a daunting biological problem. This review focuses on a few examples in which the molecular and biochemical basis for splice site selection is better understood.

Mesh:

Substances:

Year:  2002        PMID: 11868989      PMCID: PMC5977533     

Source DB:  PubMed          Journal:  Gene Expr        ISSN: 1052-2166


  133 in total

1.  Distinct mechanisms of splicing regulation in vivo by the Drosophila protein Sex-lethal.

Authors:  B Granadino; L O Penalva; M R Green; J Valcárcel; L Sánchez
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

Review 2.  SR proteins and splicing control.

Authors:  J L Manley; R Tacke
Journal:  Genes Dev       Date:  1996-07-01       Impact factor: 11.361

3.  Defects in RNA splicing and the consequence of shortened translational reading frames.

Authors:  L E Maquat
Journal:  Am J Hum Genet       Date:  1996-08       Impact factor: 11.025

4.  A new regulatory protein, KSRP, mediates exon inclusion through an intronic splicing enhancer.

Authors:  H Min; C W Turck; J M Nikolic; D L Black
Journal:  Genes Dev       Date:  1997-04-15       Impact factor: 11.361

5.  An N-terminal truncation uncouples the sex-transforming and dosage compensation functions of sex-lethal.

Authors:  J L Yanowitz; G Deshpande; G Calhoun; P D Schedl
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

6.  Fibroblast growth factor receptor-1 alpha-exon exclusion and polypyrimidine tract-binding protein in glioblastoma multiforme tumors.

Authors:  W Jin; I E McCutcheon; G N Fuller; E S Huang; G J Cote
Journal:  Cancer Res       Date:  2000-03-01       Impact factor: 12.701

7.  U2AF homolog required for splicing in vivo.

Authors:  J Potashkin; K Naik; K Wentz-Hunter
Journal:  Science       Date:  1993-10-22       Impact factor: 47.728

8.  Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors.

Authors:  J F Cáceres; S Stamm; D M Helfman; A R Krainer
Journal:  Science       Date:  1994-09-16       Impact factor: 47.728

9.  Polypyrimidine tract-binding protein positively regulates inclusion of an alternative 3'-terminal exon.

Authors:  H Lou; D M Helfman; R F Gagel; S M Berget
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

10.  Coupling of transcription with alternative splicing: RNA pol II promoters modulate SF2/ASF and 9G8 effects on an exonic splicing enhancer.

Authors:  P Cramer; J F Cáceres; D Cazalla; S Kadener; A F Muro; F E Baralle; A R Kornblihtt
Journal:  Mol Cell       Date:  1999-08       Impact factor: 17.970

View more
  23 in total

Review 1.  The impact of splice isoforms on voltage-gated calcium channel alpha1 subunits.

Authors:  Karin Jurkat-Rott; Frank Lehmann-Horn
Journal:  J Physiol       Date:  2003-11-28       Impact factor: 5.182

2.  Nonreplicative homologous RNA recombination: promiscuous joining of RNA pieces?

Authors:  Anatoly P Gmyl; Sergey A Korshenko; Evegny V Belousov; Elena V Khitrina; Vadim I Agol
Journal:  RNA       Date:  2003-10       Impact factor: 4.942

3.  RNA recombination in vivo in the absence of viral replication.

Authors:  Andreas Gallei; Alexander Pankraz; Heinz-Jürgen Thiel; Paul Becher
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

4.  Prediction of RNA-binding proteins from primary sequence by a support vector machine approach.

Authors:  Lian Yi Han; Cong Zhong Cai; Siew Lin Lo; Maxey C M Chung; Yu Zong Chen
Journal:  RNA       Date:  2004-03       Impact factor: 4.942

5.  ATPase/helicase activities of p68 RNA helicase are required for pre-mRNA splicing but not for assembly of the spliceosome.

Authors:  Chunru Lin; Liuqing Yang; Jenny J Yang; Youliang Huang; Zhi-Ren Liu
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

6.  A novel method for the identification of conserved structural patterns in RNA: From small scale to high-throughput applications.

Authors:  Marco Pietrosanto; Eugenio Mattei; Manuela Helmer-Citterich; Fabrizio Ferrè
Journal:  Nucleic Acids Res       Date:  2016-08-31       Impact factor: 16.971

7.  FRET analyses of the U2AF complex localize the U2AF35/U2AF65 interaction in vivo and reveal a novel self-interaction of U2AF35.

Authors:  Janet Chusainow; Paul M Ajuh; Laura Trinkle-Mulcahy; Judith E Sleeman; Jan Ellenberg; Angus I Lamond
Journal:  RNA       Date:  2005-08       Impact factor: 4.942

8.  The conserved RNA recognition motif 3 of U2 snRNA auxiliary factor (U2AF 65) is essential in vivo but dispensable for activity in vitro.

Authors:  Hiren Banerjee; Andrew Rahn; Bharat Gawande; Sabine Guth; Juan Valcarcel; Ravinder Singh
Journal:  RNA       Date:  2004-02       Impact factor: 4.942

9.  Sex lethal and U2 small nuclear ribonucleoprotein auxiliary factor (U2AF65) recognize polypyrimidine tracts using multiple modes of binding.

Authors:  Hiren Banerjee; Andrew Rahn; William Davis; Ravinder Singh
Journal:  RNA       Date:  2003-01       Impact factor: 4.942

10.  Detection of alternatively spliced EMR2 mRNAs in colorectal tumor cell lines but rare expression of the molecule in colorectal adenocarcinomas.

Authors:  Gabriela Aust; Jörg Hamann; Nicole Schilling; Manja Wobus
Journal:  Virchows Arch       Date:  2003-05-22       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.